Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2014 Washington St
Newton, MA 02462Phone+1 617-219-1230Fax+1 617-831-7350
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2001 - 2004
Yale School of MedicineClass of 2001
Certifications & Licensure
MA State Medical License 2003 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Publications & Presentations
PubMed
- 31 citationsC-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors.L. Barroilhet, Junzheng Yang, Kathleen Hasselblatt, Ronald M. Paranal, Shu-Kay Ng
Oncogene. 2013-08-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
